XIAP-associated factor 1 (Xaf1) binds XIAP and re-localizes it to the nucleus, thus inhibiting XIAP activity and enhancing apoptosis [1] . Xaf1 expression is reduced or absent in tumor samples and cell lines suggesting it may function as a tumor suppressor [2] [3] [4] [5] . To further study Xaf1 function we generated Xaf1 inducible cells in the osteosarcoma cell line Saos-2. Despite Xaf1 inducing apoptosis that is dramatically enhanced by TNFα we find no evidence for an interaction between Xaf1 and XIAP. Furthermore, Xaf1 expression sensitized XIAP −/− fibroblasts to TNFα, demonstrating the existence of a novel mechanism of Xaf1 induced apoptosis distinct from antagonizing XIAP. Xaf1 expression promotes cytochrome c release that cannot be blocked by inhibition of caspase activity. This implicates a role for the mitochondrial apoptotic pathway, consistent with the ability of Bcl2 to block Xaf1 induced apoptosis. The data indicate that in Saos2 cells Xaf1 activates the mitochondrial apoptotic pathway to facilitate cytochrome c release, thus amplifying apoptotic signals from death receptors. (Mol Cell Biochem 286: [67][68][69][70][71][72][73][74][75][76] 2006) 
Introduction
Apoptosis is an evolutionarily conserved form of cell death, which plays critical roles during development, differentiation and tissue homeostasis of multi-cellular organisms. Defects in apoptosis play an important role in the pathogenesis of a number of diseases including cancer, neurodegenerative and auto-immune diseases [6] . Central mediators of the apoptotic process are the caspases. These proteases are synthesized as zymogens that are activated by either an increase in local concentration or by cleavage by other caspases (or in some cases non-caspase proteases) [7] . This can lead to a cascade of caspase activation, eventually mediating the orderly destruction of the cell [7, 8] .
Two major pathways of apoptosis are described as the death receptor (or extrinsic) and the mitochondrial (or intrinsic). In both pathways apical initiator caspases are activated which in turn activate other caspases. The extrinsic pathway is activated by ligation of death receptors such as Fas and Tumor Necrosis Factor Receptor (TNFR) with their appropriate ligand. This results in the formation of a signaling complex activating caspase 8 [9] . The intrinsic or mitochondrial pathway is regulated by members of the Bcl2 family, which either promote or inhibit apoptosis [10, 11] . This pathway can be activated by a variety of stresses including radiation and chemotherapeutic agents resulting in the release of cytochrome c and other pro-apoptotic molecules from the mitochondria into the cytosol. Cytochrome c binds to Apaf1 forming a macromolecular structure termed the apoptosome that recruits and activates caspase 9 [12] .
Apoptosis is regulated post activation of caspases, by the inhibitor of apoptosis proteins (IAPs) , that bind and inhibit the activity of caspases [13] . In many experimental systems, the X-linked inhibitor of apoptosis (XIAP) is the most potent of the IAPs, binding and inhibiting the activity of several caspases, notably caspases 3, 7 and 9 [14, 15] . In addition to the activation of caspases, efficient induction of apoptosis requires relief of IAP-mediated caspase inhibition. A number of proteins that bind and antagonize IAP function have been identified including the mitochondrial sequestered SMAC/Diablo and HtrA2/Omi [16, 17] . These proteins are released from the mitochondria in response to apoptotic signals and inhibit IAP function.
In addition to these mitochondrial sequestered proteins, other proteins have been identified that can modulate XIAP activity, including Xaf1. Xaf1 was isolated as an XIAP interacting protein in a yeast 2-hybrid screen and antagonizes XIAP caspase inhibition by direct interaction and relocalization of XIAP from cytosol to the nucleus [1, 18] . Xaf1 expression has been found to be reduced or absent in multiple tumor cell lines, in comparison to normal cells [4] . In addition, expression is lost in a subset of gastric, melanoma and colon cancer samples, suggesting that Xaf1 may function as a tumor suppressor [2, 3, 5] .
To further investigate Xaf1 function we generated Xaf1 inducible Saos-2 cell lines. Doxycycline treatment results in accumulation of Xaf1 in the nucleus and apoptosis that is enhanced by treatment with other inducers of apoptosis, most dramatically TNFα. Despite Xaf1 promoting apoptosis in this cell line, XIAP remains in the cytosol, and we see no evidence of an interaction between these proteins. In addition, expression of Xaf1 in XIAP null fibroblasts renders these cells sensitive to TNFα treatment, demonstrating a XIAP-independent function of Xaf1. Furthermore we demonstrate that Xaf1 can induce apoptosis by activation of the mitochondrial pathway, promoting cytochrome c release that cannot be inhibited by the caspase inhibitor z-VAD. Our data reveal the existence of a previously unidentified function of Xaf1 in facilitating cytochrome c release to enhance apoptosis by other signals.
Materials and methods

Transfection and cell culture
Saos-2 cells and mouse fibroblasts were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine (Cellgro), 100 U/ml penicillin and streptomycin (Cellgro). For transfections, 5 × 10 5 cells were transfected with 10 μg of expression plasmid and 2 μg of pCMV CD20 expression plasmid by calcium phosphate precipitation. Xaf1 inducibles were generated using methods previously described [19, 20] . Parallel transfections allowed isolation of Xaf1 inducibles and cells containing only the empty vector as controls. The cells were maintained in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal bovine serum (Tet System Approved FBS, BD Biosciences), 2 mM L-glutamine (Cellgro), 100 U/ml penicillin and streptomycin (Cellgro).
Immunoprecipitations and immunoblotting
Cells were harvested in Cell Lysis Buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X100 and complete proteinase inhibitors). Cellular debris was removed by centrifugation at 13000 g at 4
• C for 10 minutes. For immunoprecipitations, the cell lysates were pre-cleared with 20 μl of protein A-sepharose beads in Cell Lysis Buffer (Pierce, 20398), and then incubated with appropriate antibodies at 4
• C for 2 hours, followed by addition of 20 μl protein A-Sepharose beads and incubation at 4
• C for 30 minutes. Immunoprecipitates were washed 4 times with Cell Lysis Buffer and once with PBS. Bound proteins were eluted and resolved by SDS-PAGE, and transferred to PVDF membranes (Hybond-P, Amersham). Membranes were blocked in TBST containing 5% skimmed milk, and then incubated for 2 hours with specific antibodies (anti-Flag M2 (Sigma, F3165), anti-GFP JL-8 (Clontech, 8371-2), anti-HA F-7 (Santa Cruz, E289), anti-actin (Sigma, A2066), antiXaf1 (IMGENEX, IMG-379), and anti-XIAP (Stressgen, AAM-50). The membranes were then washed, and incubated for 1 hour with horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit antibodies (Amersham Biosciences, NA931V/NA934V). Visualization of protein bands was accomplished using enhanced chemiluminescence (Amersham Biosciences) according to the manufacturer's instructions.
Immunofluorescence microscopy
Cells grown on cover slips were fixed in 4% paraformaldehyde for 10 minutes at room temperature, rinsed three times in PBS, permeabilized with cold 0.2% TritonX-100/PBS for 5 minutes, and then blocked for 2 hours (3% BSA and 10% FBS in PBS) at room temperature. Cells were incubated with various antibodies (anti-HA F-7 Santa Cruz E289, anti-HILP/XIAP BD Transduction Laboratories 610763, at 1:200 dilution) for 2 hours at room temperature, rinsed three times in PBS, and then incubated with anti-mouse Alexa 488 or anti-rat Alexa 594 (Molecular Probes, A11008/A11007) 1:200 for 1 hour at room temperature. Cells were then washed, and stained with DAPI (30 nM) for 10 min at room temperature prior to mounting on glass slides using anti-fade (Molecular Probes).
DNA content analysis
Saos-Xaf1 inducible cells (3 × 10 5 ) were treated as indicated with doxycycline (Fisher, 2 μg/ml), TNFα (Endogen, 2 ng/ml), CHX (Fisher, cycloheximide, 4 μg/ml) Apo2L/ Trail (Cellsciences, 4 μg/ml), Z-VAD-fmk (CalBiochem, 50 μM) and Adriamycin (Sigma, 2 μg/ml). Floating and attached cells were collected, pooled washed in PBS and fixed with methanol for 2 hours at 4
• C. The cells were washed in PBS and re-suspended in PBS supplemented with propidium iodide (Fisher, 50 μg/ml) and RNAse A (Sigma, 50 μg/ml). DNA content was assessed by flow cytometry as previously described [20] , and cells with less than 2N DNA content are scored as apoptotic. Apoptosis in transfected cells is measured in the same manner, with identification of transfected cell by co-transfection of a CD20 expression plasmid and staining as previously described [20] .
Cell fractionation
Cells (1 × 10 6 ) were isolated by trypsinization. The cell pellets were washed in ice cold PBS and re-suspended in 200 μl buffer A (10 mM Hepes (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF and complete proteinase inhibitor (Calbiochem), and incubated on ice for 15 minutes. After addition of 12.5 μl 10% NP-40, the pellets were vortexed for 15 seconds and spun at 13000 rpm 1 minute at 4
• C in a microfuge. Supernatants containing cytoplasmic protein were collected. The pellets were washed 3 times with buffer A, vortexed for 15 min after addition of 30 μl buffer C (20 mM Hepes (pH 7.9), 420 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1mM PMSF and proteinase inhibitors) centrifuged 13000 rpm for 5 min at 4
• C. The supernatant containing nuclear proteins was collected [21] . The nuclear and cytoplasmic fractions were resolved by SDS PAGE and analyzed by western blot.
Cytochrome c flow cytometery assay
Cells (2 × 10 5 ) were collected by trypsinization, rinsed in PBS, and incubated in 200 μl digitonin solution (digitonin 50 μg/ml (Calbiochem), 100 mM KCl in PBS) on ice for 5 min. Cells were fixed using 500 μl of 4% paraformadehyde at room temperature for 20 minutes. Cells were washed three times in PBS, blocked for 1 hour in 500 μl blocking buffer (3% BSA, 0.05% Saponin (Sigma) in PBS), followed by incubation with anti-cytochrome c antibody 1:200 (Pharmingen, 6H2.B4) overnight at 4
• C. Cells were washed three times with PBS and incubated for 1 hour in 50 μl of anti-Ig-FITC (DAKO, F0479) diluted 1:10 in PBS. The cells were rinsed in PBS, and re-suspended in 400 μl of PBS containing RNAse A (50 μg/ml) and propidium iodine (50 μg/ml) and incubated at room temperature for 1 hour. Measurement of DNA content was assessed in FL2 and cytochrome c fluorescence was measured in FL1 using a Becton Dickenson FACScalibur.
Results
Xaf1 induces apoptosis in Saos-2 cells
We established HA-Xaf1 inducible cell lines in the human osteosarcoma tumor cell line Saos-2. Five clones that were capable of significant induction of Xaf1 in response to doxycycline treatment were analyzed in initial experiments, and compared to clones containing only empty vector. Treatment of empty vector controls demonstrated no effect of doxycycline on the growth or apoptosis of Saos2 cells (data not shown). All Xaf1 clones behaved in a similar fashion, and the results from a typical clone are presented. Treatment of doxycycline results in accumulation of detectable levels of Xaf1 by 8 hours and as previously reported (Fig. 1A) ,Xaf1 is located throughout the nucleus [1] , however, we also see predominant staining in sub-nuclear spots that have the appearance of nucleoli (Fig. 1B) .
To determine if Xaf1 expression modulates cell cycle distribution and/or induces apoptosis in Saos2 cells, Xaf1 was induced and DNA content was measured by propidium iodide staining and flow cytometry ( Fig. 1C and D) . Apoptotic cells (those with less than 2N DNA content) begin accumulating at 12 hours after doxycycline treatment and increase to around 20-25% at 24 hours. In contrast, no significant effect on the cell cycle distribution is seen, with the small changes in proportion of cells in G1, S, and G2/M most likely an indirect consequence of the loss of cells by apoptosis.
Xaf1 cooperates with TNFα in the induction of apoptosis
XIAP is a broad specificity inhibitor of apoptosis, blocking cell death induced by both the death receptor and mitochondrial apoptotic pathways by direct interaction with caspases [13] . Relief of XIAP inhibition of caspase activity by Xaf1 expression would be predicted to cooperate with multiple inducers of apoptosis. This is supported by work from other investigators, indicating that Xaf1 enhances apoptosis induced by a variety of agents [1, 18] . We tested if Xaf1 expression cooperated with the death receptor ligands TNFα and Apo2L/TRAIL in the induction of apoptosis in Saos-2 cells. Low levels of TNFα do not induce apoptosis in Saos-2 cells (2 ng/ml) [22] , however, in combination with the inhibition of protein synthesis, these cells undergo dramatic apoptosis indicating the presence of functional receptors ( Fig. 2A and 2B ).In the Xaf1 inducible cell lines, treatment with TNFα induces around 10% apoptosis in the absence of doxycycline treatment (level in parental Saos2 and control lines is 2-3%) and this is increased to 50% after induction of Xaf1 for 24 hours. This rate of apoptosis is sufficient to eliminate almost all of the cells in culture. The observation that Xaf1 clones have increased sensitivity to apoptosis compared to the empty vector controls in the absence of doxycycline is presumably a consequence of some 'leakiness' in the system, suggesting that low levels of Xaf1 undetectable by western blot inhibit cell survival. In contrast to TNFα, this level of Apo2L/TRAIL does not significantly cooperate with Xaf1 in the induction of apoptosis, even though inhibition of protein synthesis was capable of rendering these cells extremely sensitive to this ligand ( Fig. 2A and 2B ). Increasing levels of Apo2L leads to an induction of apoptosis that was enhanced by Xaf1 expression, although the cooperation was not as dramatic as with TNFα (data not shown).
Xaf1 expression rendered Saos2 cells sensitive to UV induced apoptosis. In contrast, Adriamycin was unable to cooperate with Xaf1 in the induction of apoptosis. Despite Adriamycin inducing significant apoptosis alone, expression of Xaf1 did not increase the level of apoptosis ( Fig. 2A and 2B) .
XIAP independent function of Xaf1
To determine if the synergy between Xaf1 and TNFα was a consequence of an inhibition of XIAP function we first determined if these proteins were co-localized in the cell. Xaf1 is a nuclear protein and can re-localize XIAP from the cytosol to the nucleus [1] . In absence of doxycycline treatment, the sub-cellular localization of XIAP was determined to be in the cytosol, with staining typical for that seen in other cell types for this IAP. Induction of Xaf1 expression did not change the localization or staining pattern of XIAP (Fig. 3A) .To confirm these results and obtain a more quantitative measure of the (Fig.  3B) . Comparison of the nuclear and cytoplasmic fractions indicated that almost all detectable XIAP is in the cytosol and all almost all Xaf1 is in the nucleus (Fig. 3C) . Even under conditions where Xaf1 is dramatically enhancing TNFα induced apoptosis, Xaf1 and XIAP are not co-localized.
One concern may be that in the generation of the lines, there may have been selection against cells in which Xaf1 and XIAP co-localized, since Xaf1 reduced colony formation relative to empty vector control plasmid. To test this, we transiently expressed HA-Xaf1 and Flag-XIAP in the parental Saos-2 cells, and performed immuno-precipitation to determine if there was any detectable interaction in this cell type. No interaction could be detected, nor can any co-localization be seen (Fig. 3D and data not shown) .
These experiments provide strong evidence that Xaf1 is inducing apoptosis independently of XIAP. However, it is possible that a small fraction of total Xaf1 is sufficient to inhibit XIAP function in the cytosol. To eliminate this possibility we utilized fibroblasts derived from XIAP deficient mice [23] . These cells were transfected with Xaf1 and control vector expression constructs and treated with TNFα for 24 hours. Transfected cells were identified by staining positive for the transfection marker CD20, and apoptosis was assessed by measuring DNA content. Xaf1 expression increased the sensitivity of these fibroblasts to TNFα (Fig. 3E) , clearly demonstrating a XIAP independent function of Xaf1.
Xaf1 and Xaf1+TNFα induced apoptosis require activation of the mitochondrial pathway
Although for convenience the death receptor and mitochondrial pathways are described separately, many cells require amplification of the apoptotic signal generated by death receptors through activation of the intrinsic pathway [24] . In some cell types this linking of the pathways is provided by the caspase 8 mediated cleavage of the BH3-only protein BID, this cleaved form translocates to the mitochondria triggering mitochondrial outer membrane permeabilization (MOMP) and release of cytochrome c [25, 26] . To determine if there is a requirement for activation of the mitochondrial apoptotic pathway for Xaf1 or Xaf1 and TNFα in combination to induce apoptosis, we transiently transfected the Xaf1 inducibles with Bcl2 expression constructs. The cells were treated with doxycycline, TNFα or both as indicated (Fig. 4) ,and apoptosis was assessed in the transfected population. Baculovirus p35 was utilized as a positive control, functioning as a broad specificity caspase inhibitor [27] , and inhibited apoptosis induced by both Xaf1 expression and Xaf1 and TNFα in combination. Expression of Bcl2 also inhibited all apoptosis triggered by Xaf1, and Xaf1 and TNFα in combination demonstrating that the apoptosis induced by Xaf1 requires engagement of the mitochondrial apoptotic pathway (Fig. 4) .
Xaf1 triggers cytochrome c release
Bcl2 inhibition of Xaf1 induced apoptosis indicates a requirement for activation of the mitochondrial pathway. Although activation of the mitochondrial pathway by death receptors is caspase dependent, activation of this pathway can occur in a caspase independent manner. For example p53 induces expression of the BH3 only proteins PUMA and Noxa that antagonize Bcl2 function, promoting cytochrome c release [28, 29] . If Xaf1 is functioning only to relieve IAP mediated repression of caspase activity, then we would predict that caspase activity would be necessary for the Xaf1 mediated engagement of the mitochondrial pathway, leading to the release of cytochrome c and other pro-apoptotic molecules. By use of the pan-caspase inhibitor z-VAD, we can determine if caspase activity is necessary for the release of cytochrome c from the mitochondria.
As a quantitative measure of cytochrome c release we utilized flow cytometry. Digitonin permeabilization of the cell membrane allows cytochrome c that is not retained in the mitochondria to be leached out of the cell [30] . By minor modification of this protocol, we could measure DNA content and cytochrome c fluorescence on the same cells, allowing us to demonstrate the effectiveness of z-VAD caspase inhibition. Since DNA fragmentation is dependent on caspase activity, z-VAD blocks DNA fragmentation even if cytochrome c has been released from the mitochondria. We treated the cells with doxycycline for 18 hours and measured cytochrome c release and DNA content. As a control we treated cells with cycloheximide (CHX) and TNFα, as this results in a caspase dependent release of cytochrome c. Xaf1 expression triggered cytochrome c release, as more dramatically did Xaf1+TNFα and CHX+TNFα treatment ( Fig. 5A and  B) .Addition of z-VAD efficiently blocked cytochrome c release of the CHX+TNFα treated cells, in contrast the Xaf1 mediated release of cytochrome c was unaffected by z-VAD treatment ( Fig. 5A and B) . However, z-VAD treatment resulted in complete inhibition of Xaf1 mediated DNA fragmentation, indicating successful inhibition of caspase activity by z-VAD (Fig. 5B) . Although TNFα and CHX induced dramatic release of cytochrome c, this was fully inhibited by z-VAD (Fig. 5C shows the results normalized, indicating almost 100% inhibition of cytochrome c release for TNFα and CHX treatment).
Treatment of cells with doxycycline and TNFα generates a similar level of DNA fragmentation and cytochrome c release as TNFα+CHX. In contrast although z-VAD treatment blocked DNA fragmentation efficiently, cytochrome c release was only partially blocked. This result is what we would predict as although TNFα promotes cytochrome c release by a caspase dependent mechanism, Xaf1 mediated cytochrome c release was not blocked by z-VAD. This data suggests that Xaf1 facilitates cytochrome c release independently of caspase activation, indicating that Xaf1 has apoptotic properties in addition to the relief of XIAP-mediated (or other IAP) caspase inhibition.
Discussion
We extended previous findings indicating that Xaf1 can cooperate with a number of agents in the induction of apoptosis to Saos2 cells. Xaf1 cooperated with both TNFα and Apo2L/TRAIL, although more dramatically with TNFα ( Fig. 2 and data not shown) . UV irradiation induced apoptosis was also enhanced by Xaf1 expression, however the chemotherapeutic drug Adriamycin was unable to cooperate with Xaf1, despite being capable of inducing apoptosis alone. The reason for the differences is unclear but may be related to the apoptotic pathways these agents stimulate, with Xaf1 perhaps cooperating more efficiently with death receptor signaling. Although UV can activate the mitochondrial apoptotic pathway [31] [32] [33] , in some cell types UV can cross link the Fas receptor and TNFR1, independently of their ligands [34, 35] . However, further work is required to determine if Xaf1 cooperation is limited to agents activating death receptor signaling, and why Xaf1 cooperates more efficiently with TNFα than Apo2L/TRAIL.
Cooperation between Xaf1 and death receptors such as TNFR could occur at a number of levels. XIAP can inhibit apoptosis upstream of MOMP in response to death receptor signaling, by preventing full processing of caspase 3 [36] . Expression of Xaf1 would be predicted to neutralize XIAP repression of caspases thus enhancing death receptor induced apoptosis. Although work from other investigators indicates that that Xaf1 can function in this manner in some cell types [1, 18] , the data here show no evidence for a Xaf1-XIAP interaction in Saos2 cells. Furthermore Xaf1 was able to sensitize XIAP −/− fibroblasts to TNFα, indicating that Xaf1 can promote apoptosis independently of XIAP (Fig. 6) . Further studies are required to determine what signals control the interaction of Xaf1 and XIAP and the sub-cellular localization of these proteins, as well as the functional consequences. In addition to our data showing no co-localization, Leaman et al. have shown that interferon induced induction of Xaf1 results in Xaf1 accumulation in both nucleus and cytoplasm, however XIAP remains cytoplasmic [18] . XIAP has been reported in the nucleus in a number of papers, and interestingly can relocate from the cytosol to the nucleus in response to a number of stress signals [37] [38] [39] [40] . Clearly in different cell types and/or under different conditions these proteins can locate to different sub-cellular compartments. An interesting possibility is that in response to certain stress conditions XIAP relocates to the nucleus to antagonize Xaf1 function, rather that Xaf1 antagonizing XIAP.
An obligatory role for the mitochondrial pathway in Xaf1 induced apoptosis is supported by the ability of Xaf1 alone to promote cytochrome c release, which cannot be inhibited by z-VAD. This data suggests that in Saos2 cells Xaf1 does not induce apoptosis by relief of IAP-mediated caspase inhibition. Further support for a role for the mitochondrial pathway in Xaf1 induced apoptosis is provided by our data demonstrating that Bcl2 can block Xaf1 induced apoptosis. Our data implicate Xaf1 as functioning upstream of the mitochondria in a caspase independent manner. All of the data are consistent with a role in facilitating cytochrome c release from mitochondria to amplify apoptotic signals. This may explain, at least in part, why Xaf1 cooperates with death receptor ligands such as TNFα, but not Adriamycin which itself can activate the mitochondrial apoptotic pathway.
How Xaf1 promotes cytochrome c release independently of caspase activation is unclear. A direct role at the mitochondria seems unlikely since almost all detectable Xaf1 is in the nucleus. However, since Bcl2 can inhibit Xaf1 induced apoptosis it is possible that the mechanism could involve the modulation of the level, activity, or location of BH family protein(s). A large family of Bcl2 related proteins exist including proteins that inhibit or induce apoptosis including certain BH3 only proteins that play key roles in activating this apoptotic pathway by antagonizing Bcl2-like proteins [28, 29, 41, 42] . Since Xaf1 expression is lost in a variety of tumor types and may function as a tumor suppressor further experiments to determine how Xaf1 induces apoptosis are warranted [2, 3, 5] . was supported in part by Georgia Cancer Coalition Distinguished Scholar Award GCC00032 to A.C.P, and a University of Michigan Biological Scholars Program, Department of Defense IDEA Award PC040215 and National Institutes of Health Grant GM067827 to C.S.D.
